Letter on 'European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis'.

Mark, P B; Dekkers, I; Blankestijn, P J; Leiner, T; Roditi, G

Mark, P B; Dekkers, I; Blankestijn, P J; Leiner, T; Roditi, G.

Affiliation

Mark PB; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Dekkers I; Leiden University Medical Center, Leiden, The Netherlands.
Blankestijn PJ; Department of Nephrology, University Medical Center, Utrecht, The Netherlands.
Leiner T; Department of Radiology, Utrecht University Medical Center, Utrecht, The Netherlands.
Roditi G; NHS Greater Glasgow & Clyde, Glasgow, UK.

J Eur Acad Dermatol Venereol ; 32(2): e84-e85, 2018 02.

Article in En | MEDLINE | ID: mdl-29283443

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleredema Adultorum / Scleroderma, Localized / Scleroderma, Systemic / Skin Diseases / Dermatology / Scleromyxedema / Nephrogenic Fibrosing Dermopathy / Undifferentiated Connective Tissue Diseases Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2018 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google